MAP Kinases Pathways in Gastric Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Cellular Signaling

Background:

• Gastric cancer (GC) poses a significant global health challenge, particularly in Asia and Europe.
• Mitogen-activated protein (MAP) kinases are integral to cellular processes, including proliferation, invasion, migration, and metastasis.
• The role of MAP kinases in GC is complex and warrants further investigation, especially considering their modulation by other cellular factors like miRNAs and lncRNAs.

Purpose of the Study:

• To review current knowledge on Mitogen-activated protein (MAP) kinase pathways in gastric cancer (GC).
• To highlight the unique involvement of MAPK pathways in GC compared to other cancers.
• To explore the role of H. pylori in triggering MAPK pathways in gastric carcinogenesis.

Main Methods:

• Comprehensive literature review of recent studies on MAPK pathways in gastric cancer.
• Analysis of molecular mechanisms involving MAPK signaling, miRNAs, lncRNAs, and H. pylori.
• Synthesis of current understanding of MAPK alterations in GC development and progression.

Main Results:

• MAPK pathways are significantly involved in GC proliferation, invasion, migration, and metastasis.
• Unlike other cancers, MAPK pathways present unique challenges and characteristics in GC treatment.
• H. pylori infection can initiate MAPK pathway dysregulation, contributing to gastric carcinogenesis.

Conclusions:

• MAPK signal transduction pathways are critical drivers of gastric cancer development.
• Further research into MAPK alterations in GC is essential for developing targeted therapies.
• The unique role of MAPK in GC necessitates distinct therapeutic strategies.